Clinical Trial Update: Discovery of New Cancer in the 1-year Follow-up After Ischemic Stroke in Patients at Risk: The INVISIBLE-1 Study

View source ↗

Summary

The INVISIBLE-1 trial is an ongoing study to identify newly diagnosed cancers during 1-year follow-up in patients at risk after ischemic stroke. It investigates…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer-related Stroke
• Embolic Stroke of Undetermined Source
• Occult Cancer
• Paraneoplastic Coagulopathy
• Stroke

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Cancer-related Stroke, Paraneoplastic Coagulopathy | Status: RECRUITING